TCL Archive NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned. March 14, 2008
TCL Archive New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing October 8, 2010
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005